Kaposi's sarcoma-associated herpesvirus (KSHV) is causatively linked to two B cell
lymphoproliferative disorders, multicentric Castleman's disease and primary effusion …

Disruptions of cell cycle and apoptotic regulatory control are primary hallmarks tumor cells. It
is therefore not surprising that Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8), a …

The mechanisms that control the replication state, latency versus lytic, of human
herpesviruses have been under intense investigations. Here we summarize some of the …

Kaposi's sarcoma-associated herpesvirus (KSHV) latency is central to the evasion of host
immune surveillances and induction of KSHV-related malignancies. The mechanism of …

Kaposi's sarcoma-associated herpesvirus (KSHV) belongs to the gamma herpesvirus family
and is the causative agent of various lymphoproliferative diseases in humans. KSHV, like …

During Kaposi's sarcoma (KS)–associated herpesvirus (KSHV) lytic infection, many virus-
encoded signaling molecules (eg, viral G protein–coupled receptor [vGPCR]) are produced …

This review will provide an overview of the notion that Kaposi sarcoma (KS) is a disease that
manifests under diverse and divergent circumstances. We begin with a historical …

Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiological agent of Kaposi's
sarcoma, primary effusion lymphoma (PEL), and multicentric Castleman's disease. Like …

Kaposi's sarcoma is an angioproliferative disseminated tumor of endothelial cells linked to
infection with Kaposi's sarcoma-associated herpesvirus (KSHV). AP-1 transcription factors …

Kaposi's sarcoma-associated herpesvirus (KSHV), or human herpesvirus 8, is associated
with three proliferative diseases ranging from viral cytokine-induced hyperplasia to …